Latest news with #MIM
Business Wire
10 hours ago
- Health
- Business Wire
GE HealthCare drives innovation in theranostics with latest technological advances
CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare's MIM Software introduces LesionID Pro with automated zero-click pre-processing i – an AI-powered innovation to help aid physician decision making and therapy response monitoring. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief Share With cancer accounting for over 10 million deaths globally each year, ii the rise of precision care – particularly theranostics – is offering new hope to patients. By combining advanced diagnostic imaging and radiopharmaceuticals with targeted therapies, theranostics enables a personalized, patient-centric approach that may help improve disease detection, treatment accuracy, and overall quality of life. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief of Nuclear Medicine, Associate Clinical Professor, Department of Radiological Sciences, University of California, Irvine. 'With tools like GE HealthCare's Omni Legend, StarGuide, and MIM software at our disposal, we now have the ability to visualize disease with great clarity, quantify tumor burden efficiently, and make fast, informed decisions. These advancements are not only helping enhance diagnostic accuracy and therapy monitoring but are also opening the door to dosimetry—ultimately helping improve outcomes for our patients. This is precision care in action, and it's making a real difference in patients' lives.' Central to the practice of theranostics is molecular imaging, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), which provides detailed, patient-specific insights to guide and monitor treatment. However, accessing these insights – like whole-body tumor burden, which represents the total amount of cancer is in the body – has traditionally required time-consuming manual analysis, resulting in clinical and operational challenges. In response, GE HealthCare's MIM Software is introducing LesionID Pro with automated zero-click pre-processing, i designed with AI-powered automation to help physicians access reliable whole-body tumor burden statistics without having to spend hours manually segmenting lesions, removing normal physiologic uptake, and registering multiple patient images for comparison. In addition to turning manual pre-processing into a zero-click experience, this new version of LesionID Pro comes with significant algorithm improvements that provide physicians with a precise whole-body tumor volume to review and finalize. Intuitive, user-friendly tools were intentionally designed with input from leading theranostics practitioners with the ultimate goal of making whole-body tumor burden analysis a practical clinical reality and help shorten physicians' time-to-report. 'At GE HealthCare, we are dedicated to providing clinicians the precision care tools needed for the adoption and practice of theranostics,' shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. 'We designed our portfolio of precision care solutions to evolve with healthcare system needs and help support a patient's entire care journey – from the imaging equipment needed for a noninvasive look at a patient's anatomy and treatment monitoring, to novel radiopharmaceuticals used to diagnose and monitor disease and the systems required to produce them, to the software optimized to enable data-driven decision-making. In the hands of clinicians, these tools help advance the global practice of personalized medicine and help improve patient outcomes.' Also on display at #SNMMI25, as part of GE HealthCare's comprehensive portfolio of theranostics-enabling solutions for clinical and operational excellence, are the following innovations: MINItrace Magni, iii GE HealthCare's newest cyclotron technology, designed with a small footprint (about the size of a commercial refrigerator) and the goal of providing an easy-to-site, easy-to-install solution for the reliable, in-house production of commercial PET tracers and radiometals, including Gallium-68, used in diagnostic imaging to support personalized care plans. Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities. Omni Legend is a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands by enabling clinicians to reduce dose by up to 40% iv while maintaining exceptional image quality. Supportive of the diagnostic portion of theranostics, the system continues to gain in popularity, representing the company's fastest-ever-selling PET/CT. v StarGuide is a digital SPECT/CT with a 12 CZT detector design that delivers high-quality 3D images and short scan times. Optimized for certain theranostic procedures, the system is designed to help clinicians pinpoint the size, shape, and position of lesions and monitor therapy with exceptional precision. Its flexibility in patient scanning and workflow efficiencies also support high patient throughput and help reduce complexity. For oncology patients, especially those in pain, short scans can help enhance comfort and overall experience. Aurora is an advanced dual-head SPECT/CT designed with excellent diagnostic capabilities vi and streamline workflows, offering clinicians excellent image quality and operational efficiency. Its CT has a 40 mm detector – twice the detector coverage compared to CTs of other hybrid systems vii – with the ability to reduce the dose up to 82%, viii support accurate quantitation, and help clinicians make the personalized care decisions that are at the heart of theranostics. Theranostics Pathway Manager Tile is an easy-to-use application, available on GE HealthCare's Command Center software, that is designed to simplify the time-consuming task of coordinating the theranostics care pathway. It does so by tracking patient readiness for therapy, eliminating the need for manual data gathering across disparate systems (e.g., labs, scheduling, ordering, spreadsheets), and providing a unified, up-to-date view of each patient's treatment journey. Oregon Health & Science University will be an early adopter. 'Every day counts when it comes to cancer care. The latest theranostics solutions will help our care teams more quickly and easily keep tabs on patient readiness and reduce patient coordination time—freeing up more time for clinicians to focus on direct patient care,' says Erik Mittra, M.D., Ph.D., professor of diagnostic radiology in the at Oregon Health & Science University. Altogether, GE HealthCare has the unique ability to provide solutions along every step of the theranostics care pathway. Our integrated portfolio of solutions provides clinicians with the isotopes, imaging, informatics, and molecular imaging agents necessary for the practice and advancement of precision care. For more information on GE HealthCare's innovative portfolio of theranostics-enabling solutions, please visit SNMMI show attendees are also encouraged stop by the company's booth (#638 and #1023) at New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana from June 21-24. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. i LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region. ii Cancer. World Health Organization. Published February 3, 2022. Accessed March 2, 2023. iii Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not CE marked. iv Omni Legend 21cm as compared to Discovery MI Gen1 20cm. As demonstrated in phantom testing. v Based on orders data of GE HealthCare PET/CT systems since 2010. vi Compared to NM/CT 870 DR. vii As compared to NM/CT 870 DR with Optima 540 CT. viii a ASiR-V reduces dose by 50% to 82% relative to FBP at the same image quality (Image quality as defined by low contrast detectability). viii b In clinical practice, the use of ASiR‐V may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low Contrast Detectability (LCD), Image Noise, Spatial Resolution and Artifact were assessed using reference factory protocols comparing ASiR‐V and FBP. The LCD was measured using 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using a model observer method.
ABC News
a day ago
- Business
- ABC News
Copper mining and Mount Isa go hand-in-hand. Can one survive without the other?
Dotted along an outback Queensland horizon, mining stacks rise from the red dirt below. Marking the epicentre of one of the richest mineral deposits in the world, these towering cylinders bear the residue of more than 100 years of blood, sweat and tears. For all that time, mining has sustained the city at its doorstep — Mount Isa. Eighteen months ago, Swiss commodity trader Glencore announced it would close a significant portion of its Mount Isa Mines complex — the underground copper operation — by July this year. In that time, the company has reduced the expected redundancies from 1,200 to 500. But that hasn't eased the next big threat: to shutter other key assets if government doesn't intervene. Separated only by the width of a rail track, it's hard to distinguish where the Mount Isa Mines (MIM) complex ends and the community begins. It's always been that way. Prospector John Campbell Miles stumbled upon the rocky outcrops that would become the city in 1923. A year later, Mount Isa was born. "From those days, Mount Isa has always been fighting for our existence," local historian Kim-Maree Burton said. From company takeovers to stock market turmoil to industrial disputes, the local community has weathered each storm in its path. "It's our character, regardless of the parental ownership, MIM is part and parcel of this city," she said. "Could we have a city without the mine? I don't think so. Could we have the mine without the city? I don't think so. "We're two peas in a pod, we need each other." That's a sentiment shared by many of the 19,000 residents who call the place home. A born and bred Mount Isan, former local business owner Brett Peterson wasn't surprised when Glencore announced it was ceasing operations at the underground copper site. Threats to shutter other key assets like the copper smelter in Mount Isa and copper refinery in Townsville have stoked fears far and wide. "I don't want Mount Isa to end up as a small town, there's too much happening here," he said. Mount Isa is home to one of only two copper smelters in Australia and is the only one that can process third-party product. In countries like China and Indonesia, treatment costs are heavily subsidised by local governments. In a statement, Glencore interim chief operating officer Troy Wilson said the company could not keep up. "Smelters and refineries like those in Mount Isa and Townsville must be able to compete internationally to survive," Mr Wilson said. The company admitted these assets could close "this year if we cannot reach an agreement with the Queensland or federal governments." Four-yearly maintenance on the copper smelter to the tune of $30 million is due in 2026. But Glencore is seeking a much larger bailout, making a pointed comparison to the Whyalla Steelworks, which received a $2.4 billion package in February. Queensland Premier David Crisafulli has been vocal on the need for these assets to stay operational, but neither the state nor federal government has promised any solid funding yet. "Mount Isa's been pretty good to Glencore over a long period of time, I think Glencore needs to be pretty good to Mount Isa now because that is a city on its knees," Mr Crisafulli told the ABC earlier in June. In a statement, a spokesperson for federal Minister for Industry and Innovation Tim Ayres said the Australian government was monitoring the situation and discussions were continuing. "Closure of the smelter would have downstream impacts for a number of facilities … the Australian government will work with the Queensland government on the path ahead." You only have to look at the remnants of once-bustling mining towns nearby to know what's at stake. The town of Mary Kathleen 50 kilometres from Mount Isa was born off the back of the uranium boom of the 1950s. At its peak, the community was entirely self-sufficient, with homes, a school, cinema, even an Olympic-sized swimming pool. But by 1982, when the ore deposit was exhausted, the town was stripped bare and sold off at auction. Mount Isa's population is already projected to decline, and the city council is preparing for a worst-case scenario of 50 per cent if no other projects start up. But long-time residents are confident Mount Isa won't suffer the same fate as its neighbour. "Mary Kathleen was totally different, it was a company town," Ms Burton said. President of Commerce North West Johno Neilsen points to Mount Isa's critical role as a service hub in the outback as proof the city will survive. "We've got the largest hospital in the region; health is a major employer. "That's the saving grace; there's a lot of industries that are still prevalent in town." For Mr Peterson, the looming threat of further closures isn't enough to make him pack up and abandon the city he's lived in all his life. "But we need to see some change on the horizon," he said.
Business Wire
3 days ago
- Business
- Business Wire
MetLife Investment Management Names Brian Funk President
WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced that it has named Brian Funk its president. Funk previously served as interim president and global head of Private Capital for MIM. Funk will be responsible for delivering investment performance and client growth to expand MIM's $616.9 billion in total assets under management (AUM). 1 This includes integrating PineBridge Investments, a global asset manager with approximately $100 billion in AUM, 2 into the firm, upon closing of the acquisition anticipated to occur by the end of 2025. This acquisition will significantly expand MIM's public and private credit offerings and global capabilities. 'Accelerating growth in asset management is a strategic priority for MetLife and a core deliverable of our New Frontier strategy,' said John McCallion, MetLife chief financial officer and head of MIM. 'Brian is the right leader to build on our established positions in credit and real estate and drive performance on behalf of our clients around the world. His industry expertise, deep client relationships and proven leadership make him well-positioned to guide our institutional asset management business through this next chapter of growth.' While serving as interim president, Funk also led MIM's global Private Capital business. The Private Capital team will continue to report to Funk until a successor is named. Under his leadership, the Private Capital team originated $21.6 billion in private credit transactions in 2024. Funk previously served as global head of Credit Research for MIM's Public Fixed Income business. He joined MIM as part of the firm's acquisition of Logan Circle Partners in 2017. As a leader in MIM, he has helped expand product capabilities, including playing a key role in the 2022 acquisition of Affirmative Investment Management, an impact and sustainable investing specialist firm. 'I am honored to step into the role of MIM president and lead our team of 1,100 professionals at such an important moment in the firm's growth trajectory,' Funk said. 'I'm confident we have the scale, expertise and positioning in the market to continue to grow our leading global platform and expand our solution set to make us the partner of choice for institutional investors worldwide.' About MetLife Investment Management MetLife Investment Management, the institutional asset management business of MetLife, Inc. (NYSE: MET), is a global public fixed income, small and small-mid cap equities, private capital and real estate investment manager providing tailored investment solutions to institutional investors worldwide. MetLife Investment Management provides public and private pension plans, insurance companies, endowments, funds and other institutional clients with a range of bespoke investment and financing solutions that seek to meet a range of long-term investment objectives and risk-adjusted returns over time. MetLife Investment Management has over 150 years of investment experience and, as of March 31, 2025, had $616.9 billion in total assets under management. For more information, see the total assets under management fact sheet for the quarter ended March 31, 2025 available on MetLife's Investor Relations webpage ( About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates ('MetLife'), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit Forward-Looking Statements The forward-looking statements in this news release, using words such as 'anticipate,' 'continue,' 'seek,' 'well-positioned' and 'will' are based on assumptions and expectations that involve risks and uncertainties, including the 'Risk Factors' MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife's future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements. Endnotes 1 2 As of Sept. 30, 2024. At estimated fair value.
Hans India
06-06-2025
- Politics
- Hans India
MIM Corporator Muzaffar Hussain dies of cardiac arrest
Hyderabad: In a shocking incident, AIMIM Corporator from Santosh Nagar, Mohammed Muzaffar Hussain died of cardiac arrest on Wednesday night. He had attended the 11th GHMC Council meeting earlier in the day. The corporators were shocked by the sudden death of their colleague and recollected his services rendered to the citizens of the Santosh Nagar division. The corporator had attended the GHMC Council meeting and returned to his house in Madannapet. Later, he felt unwell, and passed away while being taken to hospital. Upon learning of the sudden demise of the MIM corporator, AIMIM Chief Asaduddin Owaisi and party floor leader MLA Akbaruddin Owaisi offered condolences. AIMIM MLAs including Jafar Hussain Meraj, Ahmed Balala, Mohammed Majid Hussain, Mohd Mubeen, corporators, and other party workers visited his residence to offer condolences. Mayor Gadwal Vijayalaxmi extended heartfelt condolences to his family and loved ones. 'I am deeply saddened by the sudden passing of Mohd Muzaffar Hussain, our dedicated Corporator. His commitment to our community was unwavering, and his loss is profoundly felt.
The Hindu
04-06-2025
- General
- The Hindu
Council debates on stormwater drain planning, de-silting operations
A major planning flaw in the construction of storm water box drains as part of the Strategic Nala Development Programme is resulting in the inundation of the colonies on the lower end of the drains. The issue was flagged by the council members of the Greater Hyderabad Municipal Corporation on Wednesday, during the general body meeting. Corporator from Gaddiannaram division Baddam Prem Maheshwar Reddy pointed out that the engineers ought to have widened the drains from the lower end to the upper end. Instead, they chose to go the other way round, due to which the low-lying areas are facing the brunt. 'As the drain is widened in the upper reaches, its capacity is enhanced, and all the sewage and silt flowing in it are getting deposited in our colonies where the drain capacity is limited, hence resulting in inundation,' Mr. Prem Maheshwar Reddy complained. Kothapet corporator Naikoti Pavan Kumar too echoed this view, when he pointed out the issue of inundation faced by residents around RK Puram due to flood water arriving from LB Nagar through the newly enhanced 900 mm dia pipeline. The outlet in Alkapuri drain which is receiving the flows is not properly aligned, leading to inundation, he said. Member of Parliament Eatala Rajender raised the issue of double bedroom housing units remaining vacant at several locations and advised the government to shed the mental block of prime real estate which works against accessible housing for the poor. He also advocated for sewerage and stormwater pipelines with a planning for coming 20-30 years, as road cutting component is more expensive than the pipeline. Separation of stormwater drains from sewerage lines is the need of the hour as mixing of both is increasing the burden on the sewage treatment plants. 'Building permissions should be issued based on the carrying capacity of the sewage lines,' he said. Citing instances of inundation in Qutbullahpur and Moula Ali, he said carrying capacity of the drains has been compromised. He also stressed on devising alternatives for the unmanned railway crossings, and advised the authorities to focus on creating roads where they are not available rather than repairs to the roads where they exist. Several complaints were raised by members about absence of de-silting operations till now. BJP member Shankar Yadav said only 10-12% of de-silting operations have been completed this year so far, while pointing out the inundation due to blockage of Afzal Sagar canal due to trash. MIM corporator Mirza Saleem Baig raised questions about non-functioning streetlight, and asked why tenders had not been called earlier, when the officials knew that the agreement with the Energy Efficiency Services Limited for operation and maintenance of streetlighting would end on April 30. He claimed that 50-60% of the lights were not functioning. MLA Mohammed Majid Hussain flagged the issue of transfer stations overflowing with unlifted garbage due to the 'solid waste concessionaire refusing to lift unless paid'. With Bakrid around the corner, if trash is not lifted, it will be dumped in front of GHMC zonal offices, he threatened. GHMC Commissioner R.V. Karnan attributed the issue to the trouble between the concessionaire agency and its vendors, and assured to sort it out soon. Questions were also raised about the status of sports complexes, non-lifting of green waste, advertising policy and others. Newly elected MLC Vijaya Shanthi attended the council meeting for the first time, drawing attention. The meeting observed two minute silence for the victims of Pahalgam terrorist attack and Gulzar Houz fire accident.
